Santiago - Delayed Quote CLP
The Procter & Gamble Company (PGCL.SN)
151,200.00
-1,700.00
(-1.11%)
At close: May 2 at 11:45:36 AM GMT-4
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 14 | 10 | 22 | 22 |
Avg. Estimate | 20.74B | 22.06B | 84.28B | 86.6B |
Low Estimate | 20.32B | 21.64B | 83.71B | 84.5B |
High Estimate | 21.02B | 22.24B | 85.77B | 89.31B |
Year Ago Sales | 20.53B | 21.74B | 84.04B | 84.28B |
Sales Growth (year/est) | 1.02% | 1.50% | 0.29% | 2.75% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
PGCL.SN | -- | -- | -- | -- |
S&P 500 | 11.38% | 3.78% | 8.23% | 13.76% |
Upgrades & Downgrades
Maintains | Truist Securities: Buy to Buy | 4/25/2025 |
Upgrade | RBC Capital: Sector Perform to Outperform | 4/25/2025 |
Maintains | Raymond James: Outperform to Outperform | 4/25/2025 |
Maintains | Morgan Stanley: Overweight to Overweight | 4/25/2025 |
Maintains | Citigroup: Buy to Buy | 4/25/2025 |
Maintains | B of A Securities: Buy to Buy | 4/25/2025 |